HealthBusiness Insider Techabout 7 hours ago
Rosen Law Firm Investigates Disc Medicine Securities Claims
1 min read
Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) over allegations of misleading business information. The FDA issued a Complete Response Letter on February 13, 2026, declining to approve Disc Medicine's bitopertin drug application due to uncertainties. Disc Medicine's stock price fell 22% that day.
Level
Hype check
Tap to vote and see what everyone thinks.
